Zentiva S.A. (BVB:SCD)

Market Cap	3.15B
Revenue (ttm)	1.12B
Net Income (ttm)	231.57M
Shares Out	697.02M
EPS (ttm)	0.33
PE Ratio	13.60
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,573
Average Volume	3,001
Open	4.420
Previous Close	4.420
Day's Range	4.420 - 4.520
52-Week Range	2.720 - 4.600
Beta	0.35
RSI	71.22
Earnings Date	Nov 14, 2025

About Zentiva

Zentiva S.A. engages in the production and marketing of preparations and medicines for human use in Romania and internationally. The company develops pharmaceutical products in various therapeutic areas, such as cardiovascular diseases, anti-inflammatory and pain-relieving medications, urologists, blood diseases, gastrointestinal and metabolic disorders, central nervous system, infections, respiratory systems, and other, as well as develops generic medicines. It also offers educational materials for healthcare professionals and patients. The co...

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Employees: 963
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: SCD

Financial Performance

In 2024, Zentiva's revenue was 1.11 billion, an increase of 16.82% compared to the previous year's 953.63 million. Earnings were 250.51 million, an increase of 30.06%.